Citations

Showing 10 of 108104 citations.

High-impact chronic pain transition in surgical recipients with cervical spondylotic myelopathy
Cook, Chad E., George, Steven Z., Asher, Anthony L., Bisson, Erica F., Buchholz, Avery L., Bydon, Mohamad, Chan, Andrew K., Haid, Regis W., Mummaneni, Praveen V., Park, Paul, Shaffrey, Christopher I., Than, Khoi D., Tumialan, Luis M., Wang, Michael Y., Gottfried, Oren N., Park, Paul , Cook, Chad E., George, Steven Z., Asher, Anthony L., Bisson, Erica F., Buchholz, Avery L., Bydon, Mohamad, Chan, Andrew K., Haid, Regis W., Mummaneni, Praveen V., Park, Paul, Shaffrey, Christopher I., Than, Khoi D., Tumialan, Luis M., Wang, Michael Y., Gottfried, Oren N.

Mayo Clinic

Journal of Neurosurgery: Spine | January 28, 2022 | Volume: 37 | Issue: 1 | Pages: 31-40

10.3171/2021.11.spine211260 | PMID 35061992 Get It

OBJECTIVE High-impact chronic pain (HICP) is a recently proposed metric that indicates the presence of a severe and troubling pain-related condition. Surgery for cervical spondylotic myelopathy (CSM) is designed to halt disease transition independent of chronic pain status. To date, the prevalence of HICP in individuals with CSM and their HICP transition from presurgery is unexplored. The authors sought to define HICP prevalence, transition, and outcomes in patients with CSM who underwent surgery and identify predictors of these HICP transition groups. METHODS CSM surgical recipients were categorized as HICP at presurgery and 3 months if they exhibited pain that lasted 6–12 months or longer with at least one major activity restriction. HICP transition groups were categorized and evaluated for outcomes. Multivariate multinomial modeling was used to predict HICP transition categorization. RESULTS A majority (56.1%) of individuals exhibited HICP preoperatively; this value declined to 15.9% at 3 months (71.6% reduction). The presence of HICP was also reflective of other self-reported outcomes at 3 and 12 months, as most demonstrated notable improvement. Higher severity in all categories of self-reported outcomes was related to a continued HICP condition at 3 months. Both social and biological factors predicted HICP translation, with social factors being predominant in transitioning to HICP (from none preoperatively). CONCLUSIONS Many individuals who received CSM surgery changed HICP status at 3 months. In a surgical population where decisions are based on disease progression, most of the changed status went from HICP preoperatively to none at 3 months. Both social and biological risk factors predicted HICP transition assignment.
Effects of patient-reported outcome assessment order
Novotny, Paul J. , Dueck, Amylou C. , Satele, Daniel , Frost, Marlene H., Beebe, Timothy J. , Yost, Kathleen J. , Lee, Minji K. , Yount, Susan , Cella, David , Mendoza, Tito R. , Cleeland, Charles S. , Blinder, Victoria , Basch, Ethan , Sloan, Jeff A. , Eton, David T. , Dueck, A. C. , Mendoza, Tito , Basch, Ethan

Mayo Clinic

Clinical Trials | January 28, 2022 | Volume: 19 | Issue: 3 | Pages: 307-315

10.1177/17407745211073788 | PMID 35088616 Get It

Background In clinical trials and clinical practice, patient-reported outcomes are almost always assessed using multiple patient-reported outcome measures at the same time. This raises concerns about whether patient responses are affected by the order in which the patient-reported outcome measures are administered. Methods This questionnaire-based study of order effects included adult cancer patients from five cancer centers. Patients were randomly assigned to complete questionnaires via paper booklets, interactive voice response system, or tablet web survey. Linear Analogue Self-Assessment, Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events, and Patient-Reported Outcomes Measurement Information System assessment tools were each used to measure general health, physical function, social function, emotional distress/anxiety, emotional distress/depression, fatigue, sleep, and pain. The order in which the three tools, and domains within tools, were presented to patients was randomized. Rates of missing data, scale scores, and Cronbach’s alpha coefficients were compared by the order in which they were assessed. Analyses included Cochran–Armitage trend tests and mixed models adjusted for performance score, age, sex, cancer type, and curative intent. Results A total of 1830 patients provided baseline patient-reported outcome assessments. There were no significant trends in rates of missing values by whether a scale was assessed earlier or later. The largest order effect for scale scores was due to a large mean score at one assessment time point. The largest difference in Cronbach’s alpha between the versions for the Patient-Reported Outcomes Measurement Information System scales was 0.106. Conclusion The well-being of a cancer patient has many different aspects such as pain, fatigue, depression, and anxiety. These are assessed using a variety of surveys often collected at the same time. This study shows that the order in which the different aspects are collected from the patient is not important.
Necrotizing pancreatitis in a COVID-19 patient managed with endoscopic AXIOS stent placement
Bajaj, Suryansh , Bhatia, Unnati , Barrett, Stevi , LeGout, Jordan D. , Bi, Yan

Mayo Clinic

International Journal of Gastrointestinal Intervention | January 28, 2022 | Volume: 11 | Issue: 1 | Pages: 42-45

10.18528/ijgii210052 Get It

The Paris System for Reporting Urinary Cytology: A Meta-Analysis
Nikas, Ilias P. , Proctor, Tanja, Kleinaki, Zoi , Kleinaki, Maria, Reynolds, Jordan , Proctor, Tanja , Kleinaki, Zoi , Reynolds, Jordan P, Reynolds, Jordan P , Seide, Svenja

Mayo Clinic

Journal of Personalized Medicine | January 27, 2022 | Volume: 12 | Issue: 2 | Pages: 170

10.3390/jpm12020170 | PMID 35207658 Get It

The Paris System (TPS) for Reporting Urinary Cytology is a standardized, evidence-based reporting system, comprising seven diagnostic categories: nondiagnostic, negative for high-grade urothelial carcinoma (NHGUC), atypical urothelial cells (AUC), suspicious for high-grade urothelial carcinoma (SHGUC), HGUC, low-grade urothelial neoplasm (LGUN), and other malignancies. This study aimed to calculate the pooled risk of high-grade malignancy (ROHM) of each category and demonstrate the diagnostic accuracy of urine cytology reported with TPS. Four databases (PubMed, Embase, Scopus, Web of Science) were searched. Specific inclusion and exclusion criteria were applied, while data were extracted and analyzed both qualitatively and quantitatively. The pooled ROHM was 17.70% for the nondiagnostic category (95% CI, 0.0650; 0.3997), 13.04% for the NHGUC (95% CI, 0.0932; 0.1796), 38.65% for the AUC (95% CI, 0.3042; 0.4759), 12.45% for the LGUN (95% CI, 0.0431; 0.3101), 76.89 for the SHGUC (95% CI, 0.7063; 0.8216), and 91.79% for the HGUC and other malignancies (95% CI, 0.8722; 0.9482). A summary ROC curve was created and the Area Under the Curve (AUC) was 0.849, while the pooled sensitivity was 0.669 (95% CI, 0.589; 0.741) and false-positive rate was 0.101 (95% CI, 0.063; 0.158). In addition, the pooled DOR of the included studies was 21.258 (95% CI, 14.336; 31.522). TPS assigns each sample into a diagnostic category linked with a specific ROHM, guiding clinical management.
A Novel USP25::PDGFRA Gene Fusion in a 78 Year Old Patient with a Myeloid Neoplasm
Dalland, Joanna , Blackburn, Patrick R. , Reichard, Kaaren K. , Johnson, Sarah H. , Smadbeck, James B. , Vasmatzis, George , Hoppman, Nicole L., Xu, Xinjie, Greipp, Patricia T. , Peterson, Jess F. , Dalland, Joanna C , Peterson, Jess F , Greipp, Patricia T , Baughn, Linda B.

Mayo Clinic

Laboratory Medicine | January 27, 2022 | Volume: 53 | Issue: 5 | Pages: e134-e138

10.1093/labmed/lmac010 | PMID 35217871 Get It

Abstract The World Health Organization category of myeloid/lymphoid neoplasms with eosinophilia and PDGFRA rearrangements is composed of a heterogeneous group of neoplasms that can present as a myeloproliferative neoplasm, acute myeloid leukemia, myeloid sarcoma, or lymphoblastic leukemia/lymphoma. The overall outcome of these neoplasms is favorable with imatinib therapy. Herein, we describe an adult female patient with a myeloid neoplasm accompanied by eosinophilia and a novel USP25::PDGFRA gene fusion.
Physician Training for Electrocardiogram Interpretation: A Systematic Review and Meta-Analysis
Oh, So-Young , Cook, David A. , Gerven, Pascal W M Van , Nicholson, Joseph, Fairbrother, Hilary, Smeenk, Frank W J M, Pusic, Martin , Pusic, Martin V , Oh, So-Young , Cook, D A , Gerven, Pascal W M Van , Nicholson, Joseph, Fairbrother, Hilary, Smeenk, Frank W J M

Mayo Clinic

Academic Medicine | January 27, 2022 | Volume: 97 | Issue: 4 | Pages: 593-602

10.1097/acm.0000000000004607 | PMID 35086115 Get It

Abstract Purpose Using electrocardiogram (ECG) interpretation as an example of a widely taught diagnostic skill, the authors conducted a systematic review and meta-analysis to demonstrate how research evidence on instruction in diagnosis can be synthesized to facilitate improvement of educational activities (instructional modalities, instructional methods, and interpretation approaches), guide the content and specificity of such activities, and provide direction for research. Method The authors searched PubMed/MEDLINE, Embase, Cochrane CENTRAL, PsycInfo, CINAHL, ERIC, and Web of Science databases through February 21, 2020, for empirical investigations of ECG interpretation training enrolling medical students, residents, or practicing physicians. They appraised study quality with the Medical Education Research Study Quality Instrument and pooled standardized mean differences (SMDs) using random effects meta-analysis. Results Of 1,002 articles identified, 59 were included (enrolling 17,251 participants). Among 10 studies comparing instructional modalities, 8 compared computer-assisted and face-to-face instruction, with pooled SMD 0.23 (95% CI, 0.09, 0.36) indicating a small, statistically significant difference favoring computer-assisted instruction. Among 19 studies comparing instructional methods, 5 evaluated individual versus group training (pooled SMD −0.35 favoring group study [95% CI, −0.06, −0.63]), 4 evaluated peer-led versus faculty-led instruction (pooled SMD 0.38 favoring peer instruction [95% CI, 0.01, 0.74]), and 4 evaluated contrasting ECG features (e.g., QRS width) from 2 or more diagnostic categories versus routine examination of features within a single ECG or diagnosis (pooled SMD 0.23 not significantly favoring contrasting features [95% CI, −0.30, 0.76]). Eight studies compared ECG interpretation approaches, with pooled SMD 0.92 (95% CI, 0.48, 1.37) indicating a large, statistically significant effect favoring more systematic interpretation approaches. Conclusions Some instructional interventions appear to improve learning in ECG interpretation; however, many evidence-based instructional strategies are insufficiently investigated. The findings may have implications for future research and design of training to improve skills in ECG interpretation and other types of visual diagnosis.
Lack of defined apheresis collection criteria in publicly available CAR‐T cell clinical trial descriptions: Comprehensive review of over 600 studies
Thibodeaux, Suzanne R. , Aqui, Nicole A., Park, Yara A. , Su, Leon , Zubair, Abba C. , Liu, Hien , Su, Leon L , Zubair, Abba C , Schneiderman, Jennifer , Winters, Jeffrey L. , Schwartz, Joseph

Mayo Clinic

Journal of Clinical Apheresis | January 27, 2022 | Volume: 37 | Issue: 3 | Pages: 223-236

10.1002/jca.21964 | PMID 35085413 Get It

AbstractBackgroundChimeric antigen receptor T (CAR‐T) cell successes have encouraged continued clinical study. Apheresis collection of starting material for CAR‐T cell therapy product manufacturing is critical but described approaches suggest variability and clinical guidelines are currently lacking. The goal of this study was to gather and assess variability in apheresis collection descriptions in publicly available CAR T‐cell therapy clinical trials.Study designWe searched clinicaltrials.gov (a publicly available clinical trial database) for “chimeric antigen receptor T cells” on July 01, 2020 and studies accessed July 30, 2020‐August 15, 2020. Data collected included date posted, study characteristics, apheresis mentions (number, location, and context), laboratory parameters and transfusion allowances. Apheresis context was analyzed using a qualitative inductive approach of grounded theory method with open coding. Text was classified into 37 context codes, grouped into 12 categories, and then consolidated into patient, procedure, product, and miscellaneous themes.ResultsApheresis was mentioned 1044 times in 322 (51.9%) of 621 total studies. Laboratory parameters mentioned included white blood cells (100 studies), absolute neutrophil count (220 studies), absolute lymphocyte count (102 studies), CD3+ cell (38 studies), hemoglobin (233 studies, 54 studies specified transfusion allowance), and platelet (269 studies, 48 studies specified transfusion allowance).ConclusionsApheresis collection of CAR‐T cell products is not well‐defined in clinical study descriptions and the context is inconsistent. Laboratory parameters useful for apheresis collection are variably present and do not consistently align with current practices. Further exploration, and clinical guideline development will encourage alignment of apheresis collections for CAR‐T cell products.
Extracapsular Silicone Rupture: Silicone Ductogram on Mammography
Sae-Kho, Tiffany M. , Valencia, Elizabeth

Mayo Clinic

Journal of Breast Imaging | January 27, 2022 | Volume: 4 | Issue: 1 | Pages: 102-103

10.1093/jbi/wbab050 Get It

Aspirin, Statins, Non-aspirin NSAIDs, Metformin, and the Risk of Biliary Cancer: A Swedish Population-Based Cohort Study
Marcano-Bonilla, Lorena , Schleck, Cathy D., Harmsen, William S., Sadr-Azodi, Omid, Borad, Mitesh J., Patel, Tushar, Petersen, Gloria M., Therneau, Terry M., Roberts, Lewis R. , Brusselaers, Nele , Sadr‐Azodi, Omid , Roberts, Lewis R , Marcano-Bonilla, Lorena , Schleck, Cathy D., Harmsen, William S., Borad, Mitesh J., Patel, Tushar, Petersen, Gloria M., Therneau, Terry M., Brusselaers, Nele

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | January 27, 2022 | Volume: 31 | Issue: 4 | Pages: 804-810

10.1158/1055-9965.epi-20-1322 | PMID 35086822 Get It

Abstract Background: Chemoprevention for biliary tract cancers (BTC), which comprise intrahepatic cholangiocarcinoma (iCCA), extrahepatic cholangiocarcinoma (eCCA), and gallbladder cancer, is controversial. We examined associations between low-dose aspirin, statins, NSAIDs, and metformin with BTC risk. Methods: We used a population-based cohort of 5.7 million persons over age 18 without personal history of cancer (except nonmelanoma skin cancer), receiving at least one commonly prescribed drug between July 1, 2005, and December 31, 2012, from the Swedish Prescribed Drug Registry. Hazard ratios (HR) were calculated using age-scaled multivariable-adjusted Cox models. Results: 2,160 individuals developed BTC. Low-dose aspirin was not associated with BTC risk [HR, 0.93; 95% confidence interval (CI), 0.81–1.07], iCCA (HR, 1.21; 95% CI, 0.93–1.57), eCCA (HR, 0.80; 95% CI, 0.60–1.07), or gallbladder cancer (HR, 0.87; 95% CI, 0.71–1.06). Statins were associated with lower risk of BTC (HR, 0.66; 95% CI, 0.56–0.78), iCCA (HR, 0.69; 95% CI, 0.50–0.95), eCCA (HR 0.54; 95% CI, 0.38–0.76), and gallbladder cancer (HR, 0.72; 95% CI, 0.57–0.91). For all BTC subtypes, combined low-dose aspirin and statins were not associated with lower risk than statins alone. NSAIDs were associated with higher risk of BTC and its subtypes. Metformin was not associated with BTC risk (HR, 0.98; 95% CI, 0.82–1.18), iCCA (HR, 1.06; 95% CI, 0.77–1.48), eCCA (HR, 1.15; 95% CI, 0.82–1.61), or gallbladder cancer (HR, 0.84; 95% CI, 0.63–1.11). Conclusions: Statins were associated with a decreased risk of BTC and its subtypes. Low-dose aspirin alone was not associated with a decreased risk, and use of both was not associated with further decrease in risk beyond statins alone. Impact: Statins were most consistently associated with a decreased risk of BTC and its subtypes.
Spontaneous Coronary Artery Dissection: New Insights into This Not-So-Rare Condition
Hajj, Stephanie C. El , El Hajj, Stephanie C, Lewey, Jennifer , Hajj, Stephanie C. El , Hayes, Sharonne N.

Mayo Clinic

Annual Review of Medicine | January 27, 2022 | Volume: 73 | Issue: 1 | Pages: 339-354

10.1146/annurev-med-052819-023826 | PMID 35084994 Get It

Spontaneous coronary artery dissection (SCAD) is an uncommon but increasingly recognized cause of acute myocardial infarction (MI) among young and middle-aged women and is an important cause of pregnancy-associated MI. Over 90% of SCAD patients are women. Compared to patients with MI caused by atherosclerosis, SCAD patients have fewer cardiovascular risk factors but more often have systemic arteriopathy, most commonly fibromuscular dysplasia. Angiographically, SCAD is characterized by the presence of an intramural hematoma with or without an intimal tear. Accurate recognition of characteristic findings on coronary angiography is critical, as there are important differences in the acute and long-term management of MI caused by SCAD versus atherosclerosis. Acutely, most SCAD patients should be managed conservatively, since percutaneous revascularization is associated with more complications and SCAD-affected vessels usually heal without intervention. Randomized clinical trials and other prospective evaluations are needed, especially to clarify optimal treatment and prevention strategies.